CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with Cancer.
Edward H WilliamsThomas R FlintClaire M ConnellDaniel GiglioHassal LeeTaehoon HaEva GablenzNicholas J BirdJames M J WeaverHarry PottsCameron T WhitleyMichael A BookmanAndy G LynchHannah V MeyerSimon TavareTobias JanowitzPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
CamGFR v2 can utilize IDMS- and non-IDMS-standardized creatinine measurements and outperforms previous models. CamGFR v2 should be examined prospectively as a practice-changing standard of care for eGFR-based carboplatin dosing.